Title:
【発明の名称】RXRレチノイドレセプターに対して選択的作働剤様活性を有する化合物の医薬用途
Document Type and Number:
Japanese Patent JPH08506816
Kind Code:
A
Abstract:
Process of treatment of mammals, including humans to treat diseases or conditions of the type which are normally treated with retinoid-like compounds is disclosed, with pharmaceutical compositions containing an active compound which is a selective agonist of the RXR retinoid receptor sites in preference to the RAR retinoid receptor sites. A compound is defined to be a selective agonist of the RXR receptor site if the compound is at least approximately ten times more effective as an agonist in the RXR receptor sites than in the RAR receptor sites.
Inventors:
Chandra Ratna, Roshansa A.
Application Number:
JP51838794A
Publication Date:
July 23, 1996
Filing Date:
February 10, 1994
Export Citation:
Assignee:
ALLERGAN,INCORPORATED
International Classes:
C07D333/38; A61K31/19; A61K31/34; A61K31/341; A61K31/38; A61K31/381; A61K45/00; A61P3/00; A61P9/10; A61P17/00; A61P37/06; C07C13/48; C07C33/38; C07C33/50; C07C35/21; C07C35/52; C07C47/238; C07C47/24; C07C47/277; C07C49/225; C07C49/237; C07C49/255; C07C61/39; C07C69/618; C07C69/753; C07C69/76; C07C233/02; C07C233/58; C07D307/68; C07F9/54; (IPC1-7): C07C13/48; A61K31/19; A61K31/34; A61K31/38; A61K45/00; C07C33/38; C07C33/50; C07C35/21; C07C35/52; C07C47/238; C07C47/24; C07C47/277; C07C49/225; C07C49/237; C07C49/255; C07C61/39; C07C69/618; C07C69/753; C07C69/76; C07C233/02; C07C233/58; C07D307/68; C07D333/38
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)
Previous Patent: ヒト癌腫抗原（ＨＣＡ）、ＨＣＡ抗体、ＨＣＡ免疫アッセイ法、画像化の...
Next Patent: スピロ（２Ｈ−１−ベンゾピラン−２，４′−ピペリジン）クラス▲ＩＩ...
Next Patent: スピロ（２Ｈ−１−ベンゾピラン−２，４′−ピペリジン）クラス▲ＩＩ...